ReviewExpert opinion on drug discovery2013

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies.

Thomas P Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.